Combined application of targeted therapy and immunotherapy in chronic myeloid leukaemia

Project Information

IMMUNOTHERAPY IN CML

Grant agreement ID: 224957

Project closed

Start date 3 November 2008

End date 2 November 2012

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom